Aquestive Therapeutics, Inc. AQST Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s common stock?
- Aquestive Therapeutics, Inc. (AQST) reported common stock of 250M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s common stock changed year-over-year?
- Aquestive Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from 250M to 250M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s common stock has grown at a 489.9% compound annual growth rate (CAGR), from 35K to 250M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).